Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DREAM: Lopinavir/Ritonavir Monotherapy vs EFV/FTC/TDF Triple Therapy in HIV-1 Patients
NCT00946595Phase 3Completed
- Sponsor
- ANRS
- Start
- Nov 2009
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lopinavir + ritonavir in human immunodeficiency virus infection (HIV), sponsored by ANRS. Started Nov 2009; status: completed.
02
Drugs
lopinavir + ritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00946595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00946595.